TY - STD TI - Cancer IAfRo. Globocan 2012. http://globocan.iarc.fr. Accessed 9 Sept 2014. UR - http://globocan.iarc.fr ID - ref1 ER - TY - JOUR AU - Fulop, T. AU - Larbi, A. AU - Witkowski, J. M. AU - Kotb, R. AU - Hirokawa, K. AU - Pawelec, G. PY - 2013 DA - 2013// TI - Immunosenescence and cancer JO - Crit Rev Oncog. VL - 18 UR - https://doi.org/10.1615/CritRevOncog.2013010597 DO - 10.1615/CritRevOncog.2013010597 ID - Fulop2013 ER - TY - JOUR AU - Malas, S. AU - Harrasser, M. AU - Lacy, K. E. AU - Karagiannis, S. N. PY - 2014 DA - 2014// TI - Antibody therapies for melanoma: New and emerging opportunities to activate immunity (Review) JO - Oncol Rep. VL - 32 ID - Malas2014 ER - TY - JOUR AU - Page, D. B. AU - Postow, M. A. AU - Callahan, M. K. AU - Wolchok, J. D. PY - 2013 DA - 2013// TI - Checkpoint modulation in melanoma: an update on ipilimumab and future directions JO - Curr Oncol Rep. VL - 15 UR - https://doi.org/10.1007/s11912-013-0337-1 DO - 10.1007/s11912-013-0337-1 ID - Page2013 ER - TY - JOUR AU - Topalian, S. L. AU - Hodi, F. S. AU - Brahmer, J. R. AU - Gettinger, S. N. AU - Smith, D. C. AU - McDermott, D. F. PY - 2012 DA - 2012// TI - Safety, activity, and immune correlates of anti-PD-1 antibody in cancer JO - N Engl J Med. VL - 366 UR - https://doi.org/10.1056/NEJMoa1200690 DO - 10.1056/NEJMoa1200690 ID - Topalian2012 ER - TY - JOUR AU - Aerts, J. G. AU - Hegmans, J. P. PY - 2013 DA - 2013// TI - Tumor-specific cytotoxic T cells are crucial for efficacy of immunomodulatory antibodies in patients with lung cancer JO - Cancer Res. VL - 73 UR - https://doi.org/10.1158/0008-5472.CAN-12-3932 DO - 10.1158/0008-5472.CAN-12-3932 ID - Aerts2013 ER - TY - JOUR AU - Weide, B. AU - Zelba, H. AU - Derhovanessian, E. AU - Pflugfelder, A. AU - Eigentler, T. K. AU - Giacomo, A. M. PY - 2012 DA - 2012// TI - Functional T cells targeting NY-ESO-1 or Melan-A are predictive for survival of patients with distant melanoma metastasis JO - J Clin Oncol. VL - 30 UR - https://doi.org/10.1200/JCO.2011.40.2271 DO - 10.1200/JCO.2011.40.2271 ID - Weide2012 ER - TY - JOUR AU - Peoples, G. E. AU - Goedegebuure, P. S. AU - Smith, R. AU - Linehan, D. C. AU - Yoshino, I. AU - Eberlein, T. J. PY - 1995 DA - 1995// TI - Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide JO - Proc Natl Acad Sci U S A. VL - 92 UR - https://doi.org/10.1073/pnas.92.2.432 DO - 10.1073/pnas.92.2.432 ID - Peoples1995 ER - TY - JOUR AU - Slamon, D. J. AU - Godolphin, W. AU - Jones, L. A. AU - Holt, J. A. AU - Wong, S. G. AU - Keith, D. E. PY - 1989 DA - 1989// TI - Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer JO - Science. VL - 244 UR - https://doi.org/10.1126/science.2470152 DO - 10.1126/science.2470152 ID - Slamon1989 ER - TY - JOUR AU - Ladjemi, M. Z. AU - Jacot, W. AU - Chardes, T. AU - Pelegrin, A. AU - Navarro-Teulon, I. PY - 2010 DA - 2010// TI - Anti-HER2 vaccines: new prospects for breast cancer therapy JO - Cancer Immunol Immunother. VL - 59 UR - https://doi.org/10.1007/s00262-010-0869-2 DO - 10.1007/s00262-010-0869-2 ID - Ladjemi2010 ER - TY - JOUR AU - Schouppe, E. AU - Overmeire, E. AU - Laoui, D. AU - Keirsse, J. AU - Ginderachter, J. A. PY - 2013 DA - 2013// TI - Modulation of CD8(+) T-cell activation events by monocytic and granulocytic myeloid-derived suppressor cells JO - Immunobiology. VL - 218 UR - https://doi.org/10.1016/j.imbio.2013.07.003 DO - 10.1016/j.imbio.2013.07.003 ID - Schouppe2013 ER - TY - JOUR AU - Curiel, T. J. AU - Coukos, G. AU - Zou, L. AU - Alvarez, X. AU - Cheng, P. AU - Mottram, P. PY - 2004 DA - 2004// TI - Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival JO - Nat Med. VL - 10 UR - https://doi.org/10.1038/nm1093 DO - 10.1038/nm1093 ID - Curiel2004 ER - TY - JOUR AU - Gros, A. AU - Turcotte, S. AU - Wunderlich, J. R. AU - Ahmadzadeh, M. AU - Dudley, M. E. AU - Rosenberg, S. A. PY - 2012 DA - 2012// TI - Myeloid cells obtained from the blood but not from the tumor can suppress T-cell proliferation in patients with melanoma JO - Clin Cancer Res. VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-12-1108 DO - 10.1158/1078-0432.CCR-12-1108 ID - Gros2012 ER - TY - JOUR AU - Bates, G. J. AU - Fox, S. B. AU - Han, C. AU - Leek, R. D. AU - Garcia, J. F. AU - Harris, A. L. PY - 2006 DA - 2006// TI - Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse JO - J Clin Oncol. VL - 24 UR - https://doi.org/10.1200/JCO.2006.05.9584 DO - 10.1200/JCO.2006.05.9584 ID - Bates2006 ER - TY - JOUR AU - Sharma, S. AU - Yang, S. C. AU - Zhu, L. AU - Reckamp, K. AU - Gardner, B. AU - Baratelli, F. PY - 2005 DA - 2005// TI - Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer JO - Cancer Res. VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-05-0141 DO - 10.1158/0008-5472.CAN-05-0141 ID - Sharma2005 ER - TY - JOUR AU - Viguier, M. AU - Lemaitre, F. AU - Verola, O. AU - Cho, M. S. AU - Gorochov, G. AU - Dubertret, L. PY - 2004 DA - 2004// TI - Foxp3 expressing CD4 + CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells JO - J Immunol. VL - 173 UR - https://doi.org/10.4049/jimmunol.173.2.1444 DO - 10.4049/jimmunol.173.2.1444 ID - Viguier2004 ER - TY - JOUR AU - Lin, Y. C. AU - Mahalingam, J. AU - Chiang, J. M. AU - Su, P. J. AU - Chu, Y. Y. AU - Lai, H. Y. PY - 2013 DA - 2013// TI - Activated but not resting regulatory T cells accumulated in tumor microenvironment and correlated with tumor progression in patients with colorectal cancer JO - Int J Cancer. VL - 132 UR - https://doi.org/10.1002/ijc.27784 DO - 10.1002/ijc.27784 ID - Lin2013 ER - TY - JOUR AU - Miyara, M. AU - Yoshioka, Y. AU - Kitoh, A. AU - Shima, T. AU - Wing, K. AU - Niwa, A. PY - 2009 DA - 2009// TI - Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor JO - Immunity. VL - 30 UR - https://doi.org/10.1016/j.immuni.2009.03.019 DO - 10.1016/j.immuni.2009.03.019 ID - Miyara2009 ER - TY - JOUR AU - Gabrilovich, D. I. AU - Ostrand-Rosenberg, S. AU - Bronte, V. PY - 2012 DA - 2012// TI - Coordinated regulation of myeloid cells by tumours JO - Nat Rev Immunol. VL - 12 UR - https://doi.org/10.1038/nri3175 DO - 10.1038/nri3175 ID - Gabrilovich2012 ER - TY - JOUR AU - Gabrilovich, D. I. AU - Nagaraj, S. PY - 2009 DA - 2009// TI - Myeloid-derived suppressor cells as regulators of the immune system JO - Nat Rev Immunol. VL - 9 UR - https://doi.org/10.1038/nri2506 DO - 10.1038/nri2506 ID - Gabrilovich2009 ER - TY - JOUR AU - Filipazzi, P. AU - Valenti, R. AU - Huber, V. AU - Pilla, L. AU - Canese, P. AU - Iero, M. PY - 2007 DA - 2007// TI - Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine JO - J Clin Oncol. VL - 25 UR - https://doi.org/10.1200/JCO.2006.08.5829 DO - 10.1200/JCO.2006.08.5829 ID - Filipazzi2007 ER - TY - JOUR AU - Ostrand-Rosenberg, S. PY - 2010 DA - 2010// TI - Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity JO - Cancer Immunol Immunother. VL - 59 UR - https://doi.org/10.1007/s00262-010-0855-8 DO - 10.1007/s00262-010-0855-8 ID - Ostrand-Rosenberg2010 ER - TY - JOUR AU - Raber, P. AU - Ochoa, A. C. AU - Rodriguez, P. C. PY - 2012 DA - 2012// TI - Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: mechanisms of T cell suppression and therapeutic perspectives JO - Immunol Invest. VL - 41 UR - https://doi.org/10.3109/08820139.2012.680634 DO - 10.3109/08820139.2012.680634 ID - Raber2012 ER - TY - JOUR AU - Weide, B. AU - Martens, A. AU - Zelba, H. AU - Stutz, C. AU - Derhovanessian, E. AU - Giacomo, A. M. PY - 2014 DA - 2014// TI - Myeloid-derived suppressor cells predict survival of patients with advanced melanoma: comparison with regulatory T cells and NY-ESO-1- or melan-A-specific T cells JO - Clin Cancer Res. VL - 20 UR - https://doi.org/10.1158/1078-0432.CCR-13-2508 DO - 10.1158/1078-0432.CCR-13-2508 ID - Weide2014 ER - TY - JOUR AU - Gabitass, R. F. AU - Annels, N. E. AU - Stocken, D. D. AU - Pandha, H. A. AU - Middleton, G. W. PY - 2011 DA - 2011// TI - Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13 JO - Cancer Immunol Immunother. VL - 60 UR - https://doi.org/10.1007/s00262-011-1028-0 DO - 10.1007/s00262-011-1028-0 ID - Gabitass2011 ER - TY - JOUR AU - Meyer, C. AU - Cagnon, L. AU - Costa-Nunes, C. M. AU - Baumgaertner, P. AU - Montandon, N. AU - Leyvraz, L. PY - 2014 DA - 2014// TI - Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab JO - Cancer Immunol Immunother. VL - 63 UR - https://doi.org/10.1007/s00262-013-1508-5 DO - 10.1007/s00262-013-1508-5 ID - Meyer2014 ER - TY - JOUR AU - McElhaney, J. E. AU - Zhou, X. AU - Talbot, H. K. AU - Soethout, E. AU - Bleackley, R. C. AU - Granville, D. J. PY - 2012 DA - 2012// TI - The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines JO - Vaccine. VL - 30 UR - https://doi.org/10.1016/j.vaccine.2012.01.015 DO - 10.1016/j.vaccine.2012.01.015 ID - McElhaney2012 ER - TY - JOUR AU - Mittendorf, E. A. AU - Clifton, G. T. AU - Holmes, J. P. AU - Clive, K. S. AU - Patil, R. AU - Benavides, L. C. PY - 2012 DA - 2012// TI - Clinical trial results of the HER-2/neu (E75) vaccine to prevent breast cancer recurrence in high-risk patients: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02 JO - Cancer. VL - 118 UR - https://doi.org/10.1002/cncr.26574 DO - 10.1002/cncr.26574 ID - Mittendorf2012 ER - TY - JOUR AU - Schneble, E. J. AU - Berry, J. S. AU - Trappey, F. A. AU - Clifton, G. T. AU - Ponniah, S. AU - Mittendorf, E. PY - 2014 DA - 2014// TI - The HER2 peptide nelipepimut-S (E75) vaccine (NeuVax) in breast cancer patients at risk for recurrence: correlation of immunologic data with clinical response JO - Immunotherapy. VL - 6 UR - https://doi.org/10.2217/imt.14.22 DO - 10.2217/imt.14.22 ID - Schneble2014 ER - TY - JOUR AU - Benavides, L. C. AU - Gates, J. D. AU - Carmichael, M. G. AU - Patil, R. AU - Holmes, J. P. AU - Hueman, M. T. PY - 2009 DA - 2009// TI - The impact of HER2/neu expression level on response to the E75 vaccine: from U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02 JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-08-1126 DO - 10.1158/1078-0432.CCR-08-1126 ID - Benavides2009 ER - TY - JOUR AU - Diaz-Montero, C. M. AU - Salem, M. L. AU - Nishimura, M. I. AU - Garrett-Mayer, E. AU - Cole, D. J. AU - Montero, A. J. PY - 2009 DA - 2009// TI - Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy JO - Cancer Immunol Immunother. VL - 58 UR - https://doi.org/10.1007/s00262-008-0523-4 DO - 10.1007/s00262-008-0523-4 ID - Diaz-Montero2009 ER - TY - JOUR AU - Nagaraj, S. AU - Gupta, K. AU - Pisarev, V. AU - Kinarsky, L. AU - Sherman, S. AU - Kang, L. PY - 2007 DA - 2007// TI - Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer JO - Nat Med. VL - 13 UR - https://doi.org/10.1038/nm1609 DO - 10.1038/nm1609 ID - Nagaraj2007 ER - TY - JOUR AU - Poschke, I. AU - Mougiakakos, D. AU - Hansson, J. AU - Masucci, G. V. AU - Kiessling, R. PY - 2010 DA - 2010// TI - Immature immunosuppressive CD14 + HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign JO - Cancer Res. VL - 70 UR - https://doi.org/10.1158/0008-5472.CAN-09-3767 DO - 10.1158/0008-5472.CAN-09-3767 ID - Poschke2010 ER - TY - JOUR AU - Nagaraj, S. AU - Schrum, A. G. AU - Cho, H. I. AU - Celis, E. AU - Gabrilovich, D. I. PY - 2010 DA - 2010// TI - Mechanism of T cell tolerance induced by myeloid-derived suppressor cells JO - J Immunol. VL - 184 UR - https://doi.org/10.4049/jimmunol.0902661 DO - 10.4049/jimmunol.0902661 ID - Nagaraj2010 ER - TY - JOUR AU - Griffiths, R. W. AU - Elkord, E. AU - Gilham, D. E. AU - Ramani, V. AU - Clarke, N. AU - Stern, P. L. PY - 2007 DA - 2007// TI - Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival JO - Cancer Immunol Immunother. VL - 56 UR - https://doi.org/10.1007/s00262-007-0318-z DO - 10.1007/s00262-007-0318-z ID - Griffiths2007 ER - TY - JOUR AU - Liyanage, U. K. AU - Moore, T. T. AU - Joo, H. G. AU - Tanaka, Y. AU - Herrmann, V. AU - Doherty, G. PY - 2002 DA - 2002// TI - Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma JO - J Immunol. VL - 169 UR - https://doi.org/10.4049/jimmunol.169.5.2756 DO - 10.4049/jimmunol.169.5.2756 ID - Liyanage2002 ER -